Cart
sales@molnova.com
CYP1B1-IN-5
CAS No. 176442-56-1
CYP1B1-IN-5( —— )
Catalog No. M36491 CAS No. 176442-56-1
CYP1B1-IN-5 is a selective and potent cytochrome P450 1B1 (CYP1B1) inhibitor with an IC50 of 4.7 nM.CYP1B1-IN-5 can be used for the study of metabolism-related diseases.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 459 | In Stock |
|
| 10MG | 657 | In Stock |
|
| 25MG | 1026 | In Stock |
|
| 50MG | 1386 | In Stock |
|
| 100MG | 1832 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 3655 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCYP1B1-IN-5
-
NoteResearch use only, not for human use.
-
Brief DescriptionCYP1B1-IN-5 is a selective and potent cytochrome P450 1B1 (CYP1B1) inhibitor with an IC50 of 4.7 nM.CYP1B1-IN-5 can be used for the study of metabolism-related diseases.
-
DescriptionCYP1B1-IN-5 (Compound 6q) is a potent and selective cytochrome P450 1B1 (CYP1B1) inhibitor with an IC50 of 4.7 nM.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetP450
-
RecptorP450
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number176442-56-1
-
Formula Weight349.12
-
Molecular FormulaC14H8INO2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1OC(=NC=2C1=CC=CC2)C3=CC=C(I)C=C3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Yi L, et al. A new class of CYP1B1 inhibitors derived from bentranil. Bioorg Med Chem Lett. 2022 Dec 21;80:129112.?
molnova catalog
related products
-
MS-PPOH
MS-PPOH is a potent and selective inhibitor of cytochrome P450 (CYP) epoxygenase, specifically inhibiting CYP2C8 and CYP2C9 with IC50 values of 15 and 11 μM, respectively.
-
2,6-Dimethoxyquinone
2, 6-dimethoxy-1, 4-benzoquinone is a member of the class of compounds known as P-benzoquinones.
-
Harman hydrochloride
Harman hydrochloride can directly induce CYP1A1 gene expression in an AhR-dependent manner and may represent a novel mechanism by which harman promotes mutagenicity, co-mutagenicity and carcinogenicity.
